U S Physical Therapy USPH
- Market cap
- $1.3B
- PE
- 101×
- 10y median 42.1×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.6×
- EV/EBIT
- 19.8×
- Revenue, 12 months
- $812.2M
- +11% on a year ago
- Net margin
- 4.0%
- Free cash flow yield
- 4.8%
U S Physical Therapy trades at 101× trailing earnings, pricier than 100% of the last ten years. Revenue was $812.2M over the last twelve months, up 11% on a year earlier with a 4% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $150M+8% | $154.8M+10% | $155.7M+5% | $167.2M+10% | $168M+12% | $180.4M+17% | $183.8M+18% | $197.3M+18% | $197.1M+17% | $202.7M+12% | $198.3M+8% | $214.1M+9% | |
| Gross profit | $27.9M+4% | $30.5M+10% | $28.4M−8% | $33.9M+5% | $29.1M+4% | $32.5M+7% | $31.1M+9% | $41.6M+23% | $36.9M+27% | $40.1M+23% | $32.8M+5% | $41.9M+1% |
| SG&A | $12M+1% | $13.9M+17% | $14.1M+2% | $14.2M+17% | $14.4M+19% | $15.6M+12% | $16.2M+15% | $17.5M+23% | $17.4M+21% | $18.1M+16% | $18.3M+13% | $19M+9% |
| $15.9M+7% | −$880K | $14.9M−12% | $15.6M−22% | $12.8M−19% | $19.7M | $19.6M+32% | $24.9M+60% | $25.3M+97% | $16.8M−15% | $12.5M−37% | $21.9M−12% | |
| Interest expense | $2.1M+4% | $2M−10% | $2M−23% | $2M−25% | $2M−4% | $2M+2% | $2.3M+16% | $2.4M+22% | $2.4M+19% | $2.4M+15% | $2.8M+23% | $3.2M+33% |
| Pre-tax income | $15.8M−2% | $106K−98% | $14.8M+3% | $14.8M−23% | $12.3M−22% | $18.3M+17185% | $17.3M+17% | $22.7M+53% | $22.9M+85% | $15M−18% | $10.6M−39% | $19.1M−16% |
| $3.6M+11% | $1.4M+15% | $3.1M+6% | $3.1M−27% | $2.6M−28% | $5.8M+317% | $3.9M+23% | $4.9M+60% | $5.2M+105% | $5.8M−1% | $2.4M−38% | $4.2M−16% | |
| Net income | $9.3M−3% | $656K−75% | $8M+9% | $7.5M−31% | $6.6M−28% | $9.2M+1309% | $9.9M+23% | $12.4M+65% | $13.1M+98% | $4.2M−55% | $5M−49% | $9.9M−20% |
| $0.51−29% | $0.04−80% | $0.46−21% | $0.47−27% | $0.39−24% | $0.61+1425% | $0.80+74% | $0.58+23% | $0.48+23% | $0.27−56% | −$0.12 | $0.25−57% | |
| 15M+15% | 15M+15% | 15M+15% | 15.1M+10% | 15.1M+1% | 15.1M+1% | 15.1M+1% | 15.2M+1% | 15.2M+1% | 15.2M+1% | 15.2M+0% | 15.1M−1% |
EPS, diluted: 13 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 13 periods, Q4 FY10 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest U S Physical Therapy's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| USPHU S Physical Therapy | $1.3B | 101× | 42.1× | 1.6× | +11% | 4.0% | |
| PNTGPennant | $1.5B | 46.5× | 47.0× | 1.3× | +38% | 2.9% | |
| OMDAOmada Health | $1.2B | 316× | 341× | 3.7× | +48% | 1.4% | |
| ARDTArdent Health | $1.7B | 22.3× | 8.5× | 0.3× | +3% | 1.2% | |
| HCSGHealthcare Services | $1.7B | 14.7× | 26.1× | 0.9× | +4% | 6.6% | |
| PGNYProgyny | $2.2B | 31.5× | 55.1× | 1.7× | +6% | 6.0% | |
| ADUSAddus HomeCare | $2.3B | 21.4× | 32.4× | 1.5× | +16% | 7.1% | |
| MDPediatrix Medical | $2.4B | 14.0× | 13.4× | 1.2× | +1% | 9.0% | |
| PRVAPrivia Health | $2.9B | 107× | 158× | 1.2× | +24% | 1.2% | |
| AVAHAveanna Healthcare | $2.9B | 10.9× | 21.8× | 1.1× | +20% | 10.6% | |
| SBCSBC Medical | $543M | 11.2× | 8.2× | 3.1× | −7% | 28.0% | |
| Peer median | $2B | 21.8× | 29.2× | 1.3× | +11% | 6.3% |
More on U S Physical Therapy
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .